Alliance Pharma
Entry Date
May 2025
Sector
Consumer Healthcare
Geographic Footprint
Global
USP
Leading Brands in Niche Categories
TRY THE UK's #1 SILICONE SCAR TREATMENT
Global consumer health platform with a market leading portfolio, mainly addressing skin damage and the effects of ageing.
Investment Rationale
- Asset-light business with high margins and strong cash flow
- Strong, sustainable market tailwinds based on demographics
- Defensive revenues, with significant barriers to entry
290+
Employees
£179m
Revenue
42%
of LDG NAV
£282bn
TAM
Alliance Products
